TIG has teamed up with other groups within UCL and KU Leuven in Belgium to develop novel low-risk imaging tools and techniques that can be used before and during surgery for diagnosis, treatment and therapy on unborn babies with severe birth defects. These tools and techniques will enable surgeons to better plan and perform operations on unborn babies with a range of debilitating abnormalities.
The project recently began a £10million 7-year grant from the Wellcome Trust and the EPSRC under the ‘Innovative Engineering for Health’ Initiative, to revolutionise the field of fetal therapy and surgery. Led by Professor Sebastien Ourselin (UCL), GIFT-Surg consists of a collaborative team of over 41 researchers, between University College London and KU Leuven and their associated hospitals.
Further details can be found at www.gift-surg.ac.uk.